相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide
Benedetta Rambaldi et al.
BLOOD ADVANCES (2021)
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis
Scott R. Goldsmith et al.
BLOOD (2021)
Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching
Garcia-Cadenas Irene et al.
BONE MARROW TRANSPLANTATION (2021)
Early CD4+T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation
Ichelle van Roessel et al.
CYTOTHERAPY (2020)
Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
Johan Torlen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression
Lucas P. Wachsmuth et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL
Peter Dreger et al.
BLOOD ADVANCES (2019)
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
Armin Rashidi et al.
BLOOD ADVANCES (2019)
Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD
Nelli Bejanyan et al.
BLOOD ADVANCES (2018)
Halfway there: the past, present and future of haploidentical transplantation
M. Slade et al.
BONE MARROW TRANSPLANTATION (2017)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
F. M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution
Hisham Abdel-Azim et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention
F. Khimani et al.
BONE MARROW TRANSPLANTATION (2017)
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
Abraham S. Kanate et al.
BLOOD (2016)
Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis
Nilanjan Ghosh et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection
Rohtesh S. Mehta et al.
VIRULENCE (2016)
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
Joseph Pidala et al.
HAEMATOLOGICA (2015)
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
Joseph Pidala et al.
HAEMATOLOGICA (2015)
Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice
Sudipto Ganguly et al.
BLOOD (2014)
Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
Jennifer A. Kanakry et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
Christopher G. Kanakry et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation
Stefan O. Ciurea et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
Joseph Pidala et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Memory B cells protect from CMV infection in the absence of T cells.
Thomas H. Winkler et al.
BLOOD (2006)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
分享论文
